Kimya Group
Kimya Group is a privately held Iranian industrial conglomerate that operates an integrated petrochemical, chemical, and pharmaceutical value chain across seven wholly-owned subsidiaries, producing ethoxylated surfactants, glycols, amines, pharmaceutical APIs, and controlled narcotic APIs for domestic and export industrial buyers.
- Company typePrivate
- Founded1994
- HeadquartersTehran, Iran
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kimya Group does
Kimya Group (گروه کیمیا) is an Iranian privately held industrial conglomerate founded in 1994 and headquartered in Tehran, operating an integrated petrochemical-to-pharmaceutical value chain across seven wholly-owned subsidiaries. Its petrochemical segment includes Petronad Petrochemical, Damoon Petrochemical (80,000 tons/year of aromatic products from pyrolysis gasoline at the Mahshahr Petrochemical Special Economic Zone), and Petrokimya Emrooz (190,000 tons/year of phenol, acetone, BPA, epoxy resin, epichlorohydrin, and pharmaceutical intermediates in the Makran region, backed by approximately $340 million of investment). Its chemical segment, anchored by Kimyagaran Emrooz Chemical with a 30-year operating history, produces 62 ethoxylated surfactants, the full PEG series (PEG 200 through PEG 10000), polysorbates (PS 20, 60, 80), glycols (MEG, DEG, TEG, MPG, DPG), methyl and ethanol amines, sulfonated products (SLES, LABSA), choline chloride, HPEG/TPEG 2400 polycarboxylate ether superplasticizers, and TETROL antifreeze. Its pharmaceutical segment — through Parand Darou, Apira Pharma, and Kimyagaran Emrooz Pharmaceutical (established 2024) — produces generic APIs (acetaminophen, metronidazole, aspirin, metformin HCl, mefenamic acid, mesalazine), pharmaceutical glycerin, controlled narcotic APIs (morphine, codeine, thebaine, oxycodone, buprenorphine, methadone), and finished dosage forms, supplements, and specialty foods. Disclosed subsidiary revenues total approximately $335 million (Petrokimya Emrooz at $280M and Damoon at $55M), with an additional Phase 1 projection of $6.5 million from Pharmaceutical Kimyagaran.
The group operates as a B2B enterprise with direct field sales from each subsidiary, serving industrial buyers across chemical manufacturing, pharmaceutical manufacturing, food, cosmetics and personal care, oil and gas, construction, textile, detergent, and agriculture/animal husbandry. Products are sold both to the domestic Iranian market and to international export channels, supported by trade-show participation (Iran International Beauty Exhibition, Iran Oil/Gas/Refining/Petrochemical exhibitions, Iran Petrochemical Forum) and a corporate website. Customer segments span nine business units with no named anchor accounts, pricing is not publicly disclosed, and the revenue model is one-time product sales rather than subscription or licensing. Strategic positioning rests on integration advantage (capturing margin from ethylene-oxide-derived intermediates through APIs to finished drugs), regulatory compliance under Iranian FDA and NIPC/PSEZ coordination, and a broad 100+ product SKU portfolio that diversifies exposure across multiple commodity and specialty chemical cycles.
Kimya Group firmographics
Firmographics- Name
- Kimya Group
- Legal name
- Kimya Group (گروه کیمیا)
- Website
- https://kimyagroup.org
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Kimya Group is a privately held Iranian industrial conglomerate that operates an integrated petrochemical, chemical, and pharmaceutical value chain across seven wholly-owned subsidiaries, producing ethoxylated surfactants, glycols, amines, pharmaceutical APIs, and controlled narcotic APIs for domestic and export industrial buyers.
- Ownership category
- akta.pro rank
Kimya Group industry classification
Industry- Product category
- Specialty Chemicals
- NAICS
- Petrochemical Manufacturing (325110), Surface Active Agent Manufacturing (325613), Other Basic Organic Chemical Manufacturing (32519), Pharmaceutical Preparation Manufacturing (325412), Chemical Manufacturing (325)
- SIC
- Industrial Organic Chemicals (2860), Pharmaceutical Preparations (2834), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Commodity Surfactants & Detergent Base Chemicals (IMAEAAAI)
- akta.pro secondary industries
- Base Aromatics (BTX: Benzene, Toluene, Xylenes) (IMAEADAB), Industrial Alcohols & Glycols (Commodity Grade) (IMAEAAAK), Medical & Food-Contact Specialty Compounds (IMANABAK)
Keywords
Where Kimya Group is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices3 records
Markets served
Kimya Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Petrochemical Products: Sales of petrochemical products including ethoxylates, glycols, methyl amines, ethanol amines, sulfonates, and related intermediates through operating subsidiaries
- Chemical Products: Sales of chemical products including surfactants, PEGs, glycols, and specialty chemicals. This business area has 30 years of history in Kimya Group
- Pharmaceutical Products (APIs and Finished Products): Production and sales of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, narcotic APIs, and finished pharmaceutical products for domestic and export markets
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Kimya Group product offering
Product offeringCore offering
Kimya Group manufactures and sells petrochemical intermediates, specialty chemicals, and pharmaceutical active ingredients through seven operating subsidiaries. Its chemical portfolio spans 62+ ethoxylated surfactants, polyethylene glycols, glycols, methyl and ethanol amines, sulfonated surfactants, and choline chloride. Its pharmaceutical portfolio includes standard APIs (Acetaminophen, Metronidazole, Aspirin, Metformin HCL, Mefenamic Acid, Mesalazine), narcotic APIs (Morphine, Codeine, Thebaine, Oxycodone, Methadone, Buprenorphine), and finished pharmaceutical products. The petrochemical arm produces aromatic products, phenol, acetone, BPA, epoxy resin, and epichlorohydrin.
Product overview
Kimya Group is a diversified Iranian chemical and pharmaceutical conglomerate operating through three core business sectors: Petrochemical, Chemical, and Pharmaceutical. The company's chemical sector, with 30 years of experience, forms the cornerstone of its operations and includes a comprehensive portfolio of 62+ ethoxylated surfactant products (including various PEG ethers, polysorbates, and specialty ethoxylates), glycols (MEG, DEG, TEG, MPG, DPG), pharmaceutical glycerin, methyl and ethanol amines, sulfonated products, and choline chloride. The pharmaceutical sector produces Active Pharmaceutical Ingredients (APIs) including acetaminophen, metronidazole, aspirin, metformin, narcotic APIs (morphine, codeine derivatives), and finished pharmaceutical products through subsidiaries Kimyagaran Emrooz Pharmaceutical, Apira Pharma, and Parand Darou. The petrochemical sector operates through Petronad, Damoon (80,000 tons/year aromatic products), and Petrokimya Emrooz (190,000 tons/year phenol/acetone chain). Products serve diverse industries including pharmaceuticals, cosmetics, food, detergents, textiles, construction (superplasticizers), agriculture, oil & gas, and automotive.
Differentiator
Problem solved
Functional benefit
Brands
- Kimyagaran: Brand for chemical and pharmaceutical products under Kimyagaran Emrooz subsidiaries
Products and services
- Ethoxylated Surfactant Portfolio 62 ethoxylated specialty surfactants including MUD 7, SAL 2/21, NON 2-40, CAS 36, PEG 40, CO 10, OL 6/9/14, TALO 2/15/20/25, CA 20, GL 7/26, ST 308, ST 150, LAN 75, TL 8/21/45, AM 15, NOL ST, HPEG 2400, TPEG 2400, MIX 50, CAT 2-80, and LA 2-25, sold to industrial manufacturers across chemical, pharmaceutical, cosmetics, textile, and construction sectors.
- Polyethylene Glycol (PEG) Series Polyethylene glycol grades PEG 200, 300, 400, 600, 1000, 1500, 3350, 4000, 6000, 8000, and 10000 used as solvents, lubricants, dispersants, and excipients in pharmaceutical, cosmetic, and industrial formulations.
- Glycols Monoethylene Glycol (MEG), Diethylene Glycol (DEG), Triethylene Glycol (TEG), Propylene Glycol (MPG), and Dipropylene Glycol (DPG) used in antifreeze, solvents, and industrial formulations.
- Pharmaceutical Glycerin Pharmaceutical-grade glycerin for use in drug formulations and medical applications.
- Methyl Amines Mono Methyl Amine (MMA), Dimethyl Amine (DMA), Trimethyl Amine (TMA), and Methyldiethanolamine (MDEA) supplied for chemical synthesis applications.
- Ethanol Amines Monoethanolamine (MEA), Diethanolamine (DEA), and Triethanolamine (TEA) used in surfactant production and industrial formulations.
- Sulfonated Surfactants Sodium Lauryl Ether Sulfate (SLES) and Linear Alkyl Benzene Sulfonic Acid (LABSA) supplied for detergent and cleaning product formulations.
- Polysorbates Nonionic surfactants Polysorbate 20, 60, and 80 used in pharmaceuticals, food products, and cosmetics as emulsifiers and stabilizers.
- Choline Chloride Organic compound used as an animal feed additive that enhances growth performance and supports fat transport, metabolism, and cell membrane structure protection in livestock.
- Polycarboxylate Ether Superplasticizers High-performance polycarboxylate ether (PCE) superplasticizers HPEG 2400 and TPEG 2400 that significantly reduce water demand in concrete, used by construction and concrete admixture manufacturers.
- Non-Narcotic Pharmaceutical APIs Active Pharmaceutical Ingredients including Acetaminophen (with DC variant), Metronidazole, Metronidazole Benzoate, Aspirin, Metformin HCL, Mefenamic Acid, and Mesalazine sold to pharmaceutical manufacturers.
- Controlled Narcotic APIs Controlled narcotic Active Pharmaceutical Ingredients including Morphine Base and Sulfate, Codeine Base and Phosphate, Papaverine Crude and HCL, Thebaine, Noscapine Crude, Base, and HCL, Methadone HCL, Oxycodone HCL, and Buprenorphine HCL for pharmaceutical manufacturing.
- Antifreeze Fluid (TETROL) Antifreeze fluid product for automotive and industrial cooling systems, sold as a finished formulation.
- Pharmaceutical Intermediates Pharmaceutical intermediates such as Para Amino Phenol supplied to pharmaceutical manufacturers as building blocks for downstream API synthesis.
- Petronad Petrochemical Aromatic Products Aromatic petrochemical products including benzene and toluene produced by Petronad Petrochemical Company as part of Kimya Group's petrochemical sector.
- Damoon Petrochemical Aromatic Products Aromatic products from pyrolysis gasoline (DPG) including benzene and toluene produced at 80,000 tons/year capacity by Damoon Petrochemical Company in Mahshahr Petrochemical Special Economic Zone.
- Petrokimya Emrooz Phenol-Acetone Derivatives Phenol, acetone, BPA, epoxy resin, epichlorohydrin (ECH), and pharmaceutical intermediates produced by Petrokimya Emrooz Petrochemical Company in the Makran region at 190,000 tons/year capacity.
- Kimyagaran Emrooz Finished Pharmaceuticals and Specialty Foods Finished pharmaceutical products, supplements, natural and traditional medicines, and specialty foods produced by Kimyagaran Emrooz Pharmaceutical Company as part of Kimya Group's downstream pharmaceutical operations.
Companies that use Kimya Group
Customer profileSegments9 records
Ideal customer profiles1 record
Kimya Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Kimya Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- National Iranian Petrochemical Company (NIPC)coreGovernment entity overseeing Iran's petrochemical industry; Kimya Group operates in coordination with NIPC for petrochemical development and operations
- Iranian Food & Drug Administration (FDA Iran)coreRegulatory body for food and pharmaceutical products in Iran; Kimya Group's pharmaceutical subsidiaries operate under FDA Iran oversight for API and finished product approvals
- Petrochemical Special Economic Zone (PSEZ)coreSpecial economic zone managing petrochemical operations; Kimya Group's subsidiaries operate within or in coordination with PSEZ infrastructure
- Fajr Energy Persian Gulf CompanyminorEnergy company providing utilities and services to petrochemical facilities in the Persian Gulf region
- Maroun Petrochemical CompanyminorPetrochemical producer in Iran's value chain; potential raw material supplier and industry partner
- Shazand Petrochemical Company (ARPC)minorPetrochemical producer; potential supplier and industry collaboration partner
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Kimya Group competitors and assessment
Company assessmentRegional players
- SABIC: Saudi Arabia-based global petrochemical leader with major aromatics, olefins, and specialty chemical operations. Comparable regional petrochemical peer serving similar Middle East end-markets though at vastly larger scale.
Direct peers
- Marun Petrochemical Company: Major Iranian petrochemical complex producing olefins, aromatics, and downstream polymers. Listed as a Kimya Group partner and directly comparable as a domestic petrochemical peer with overlapping aromatic product exposure.
- Tabriz Petrochemical Company: Iranian petrochemical producer focused on olefins, aromatics, and polymer products. Comparable to Kimya Group's Damoon and Petrokimya Emrooz subsidiaries in petrochemical production scale and domestic market positioning.
- Golrang Industrial Group: Iranian diversified industrial conglomerate with pharmaceutical, detergent, and personal care operations. Directly comparable as a domestic peer operating across multiple consumer/industrial chemical and pharmaceutical end-markets.
- Croda International: UK-listed specialty chemicals company focused on surfactants, emollients, and active ingredients for personal care, pharma, and industrial markets. Directly comparable to Kimya Group's ethoxylated surfactants, polysorbates, and pharmaceutical-grade excipients.
- Nouryon (formerly AkzoNobel Specialty Chemicals): Global specialty chemicals producer with major positions in surfactants, ethylene oxide derivatives, and cellulosic products. Comparable to Kimya Group's ethoxylation platform and industrial chemical portfolio.
- Stepan Company: US-based specialty chemical manufacturer producing surfactants, polymers, and specialty products. Highly comparable to Kimya Group's ethoxylate, sulfonate, and PEG product lines serving personal care, cleaning, agricultural, and industrial markets.
- Shazand Petrochemical Company (ARPC): Iranian petrochemical producer operating in olefins, aromatics, and polyolefins; a current partner of Kimya Group. Directly comparable as a domestic petrochemical peer operating in the same Iranian value chain.
Broad incumbents
- BASF: Global chemicals giant with broad portfolios in petrochemicals, intermediates, surfactants, and pharma ingredients. Comparable as a broad incumbent across many of Kimya Group's product categories, though with much larger scale.
- Sinopec: Global integrated energy and chemical company with major petrochemical, aromatics, and downstream chemical production. Comparable as a broad incumbent with overlapping petrochemical-to-chemical value chain integration.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Kimya Group social profiles
Digital presenceKimya Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kimya Group leadership team
Management profileNumber of profiles
Kimya Group subsidiaries and ownership
Company hierarchySubsidiaries7 records
Kimya Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kimya Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kimya Group
What does Kimya Group do?
Kimya Group manufactures and sells petrochemical intermediates, specialty chemicals, and pharmaceutical active ingredients through seven operating subsidiaries. Its chemical portfolio spans 62+ ethoxylated surfactants, polyethylene glycols, glycols, methyl and ethanol amines, sulfonated surfactants, and choline chloride. Its pharmaceutical portfolio includes standard APIs (Acetaminophen, Metronidazole, Aspirin, Metformin HCL, Mefenamic Acid, Mesalazine), narcotic APIs (Morphine, Codeine, Thebaine, Oxycodone, Methadone, Buprenorphine), and finished pharmaceutical products. The petrochemical arm produces aromatic products, phenol, acetone, BPA, epoxy resin, and epichlorohydrin.
Is Kimya Group a public or private company?
Kimya Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Kimya Group founded?
Kimya Group was founded in 1994. It employs 11 to 50 people.
Where is Kimya Group based?
Kimya Group is headquartered in Tehran, Iran, in the Middle East region.
How does Kimya Group make money?
Three revenue lines are on record. Petrochemical Products are the primary driver. The others are chemical Products and pharmaceutical Products (APIs and Finished Products).
Who are Kimya Group's main competitors?
SABIC is listed as a regional player. Direct peers are Marun Petrochemical Company, Tabriz Petrochemical Company, Golrang Industrial Group, Croda International, Nouryon (formerly AkzoNobel Specialty Chemicals), Stepan Company and Shazand Petrochemical Company (ARPC). Broad incumbents are BASF and Sinopec.
Does Kimya Group have an API?
No public API is recorded for Kimya Group.
What industry is Kimya Group in?
Kimya Group's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEAAAI, Commodity Surfactants & Detergent Base Chemicals, with a secondary code of IMAEADAB, Base Aromatics (BTX: Benzene, Toluene, Xylenes). Its NAICS code is 325110 and its SIC code is 2860.